PedAM
Pediatric Disease Annotations & Medicines
| Disease | graft-vs-host disease |
| Phenotype | C0376545|hematological malignancies |
| Sentences | 4 |
| PubMedID- 20029442 | Patients with hematological malignancies have a risk of developing graft-versus-host disease (gvhd) following allogeneic hematopoietic stem-cell transplantation. |
| PubMedID- 23225800 | The aim of this study was to analyze the impact of lymphocyte recovery after hsct on predicting the survival, relapse, trm, and gvhd in children with hematological malignancies. |
| PubMedID- 24594618 | Haplo-hcst in combination with donor-derived umbilical cord mscs was previously shown to be safe and feasible and decreased the severity of gvhd in patients with hematological malignancies [18]. |
| PubMedID- 22982307 | Allogenic bone marrow transplantation (bmt), an important treatment for hematological malignancies, is often complicated by graft-versus-host disease (gvhd). |
Page: 1